• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

3 Classic Cases: Snap Dx #1

Poll

In this diagnostic quiz: 3 photos of classic presentations of 3 different diseases in patients of 3 generations.

Case #1

This and other slightly raised pink rimmed lesions had been present on the upper face of a 3-month-old girl for about 4 days. Clearing can be seen in the center of some of the papules. The only notable history is that the patient had been exposed to the family dog.

What caused this raised papule in a 3 month old child?

A. Tinea corporis
B. ID reaction
C. Allergic dermatitis
D. Cellulitis
Related Content
FDA Updates Flublok Label with Safety Data for Pregnant Individuals / image credit pregnancy vaccination concept / ©Dmitry Naumov/stock.adobe.com

FDA Updates Flublok Label with Safety Data for Pregnant Individuals

Grace Halsey
October 23rd 2024
Article

The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.

Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause / image courtesy of Bayer

Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause

Grace Halsey
October 17th 2024
Article

Bayer announced 12 presentations focused on symptoms of menopause and effects of its investigational oral nonhormonal medication elinzanetant.

Why Are Women Still Missing from Cardiovascular Clinical Trials? image credit ©Chinnapong/stock.adobe.com

Why Are Women Still Missing from Cardiovascular Clinical Trials?

Hayden E. Klein
October 17th 2024
Article

Women remain underrepresented in heart disease research after decades of efforts to correct the balance, affecting trial data and women's cardiovascular care.

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic / Image credit: ©sopradit/AdobeStock

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic

Sydney Jennings
October 16th 2024
Article

The FDA today accepted GSK's NDA for gepotidacin for the treatment of uncomplicated urinary tract infections in women and adolescents.

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date / image credit FDA logo ©Araki Illustrations/stock.adobe.com

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date

Grace Halsey
October 11th 2024
Article

The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.

Decrease in MHT Use over Past 2 Decades: Daily Dose / image credit: ©New Africa/AdobeStock

Decrease in MHT Use over Past 2 Decades: Daily Dose

Sydney Jennings
October 10th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.